These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 3062962
21. [Sudden cardiac death--possibilities and limits of drug therapy]. Manz M, Lüderitz B. Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403 [Abstract] [Full Text] [Related]
22. Prevention of sudden death using beta-blockers. Review of possible contributory actions. Olsson G, Rydén L. Circulation; 1991 Dec; 84(6 Suppl):VI33-7. PubMed ID: 1683608 [Abstract] [Full Text] [Related]
26. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL. Am J Cardiol; 1984 Jul 30; 54(2):7A-13A. PubMed ID: 6147079 [Abstract] [Full Text] [Related]
27. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May 30; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
34. [Secondary prevention of myocardial infarction using anti-arrhythmia agents and beta-receptor blockers]. Mösslacher H. Acta Med Austriaca; 1984 May 30; 11(1):1-8. PubMed ID: 6143463 [Abstract] [Full Text] [Related]
35. Beta-adrenergic blockers in patients with acute myocardial infarction. Furberg CD, Byington RP. Cardiovasc Clin; 1989 May 30; 20(1):235-48. PubMed ID: 2565768 [Abstract] [Full Text] [Related]
36. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system. Lucchesi BR, Kniffen FJ. Circulation; 1975 Dec 30; 52(6 Suppl):III241-7. PubMed ID: 1182977 [Abstract] [Full Text] [Related]
37. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A. Ital Heart J Suppl; 2001 Dec 30; 2(12):1278-83. PubMed ID: 11838348 [Abstract] [Full Text] [Related]
38. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ. Am J Cardiol; 2008 Dec 01; 102(11):1427-32. PubMed ID: 19026290 [Abstract] [Full Text] [Related]
39. Long-term treatment after acute myocardial infarction: antiarrhythmic therapy and prophylaxis. Which drug for which patient? Bracchetti D, Naccarella F, Palmieri M, Fulvi M, Pavesi PC. J Cardiovasc Pharmacol; 1989 Dec 01; 14 Suppl 9():S79-83. PubMed ID: 2483239 [Abstract] [Full Text] [Related]
40. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI). Avanzini F, Latini R, Maggioni A, Colombo F, Santoro E, Franzosi MG, Tognoni G. Arch Intern Med; 1995 May 22; 155(10):1041-5. PubMed ID: 7748046 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]